In December 2023, significant updates on the diagnosis and research of Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), were highlighted: Diagnostic Challenges: Persistent fatigue, cognitive difficulties, and unexplained pain remain key symptoms, but diagnosis is complex due to symptom overlap with other conditions like fibromyalgia and autoimmune diseases Research Developments: Studies explored…
In December 2023, updates on health services for Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), highlighted several key developments: Consultation Outcomes: The UK government published a summary report of responses to the 2023 consultation on the interim delivery plan for ME/CFS. These responses, along with stakeholder engagement, are shaping the final delivery…
Research and updates on viral diseases in November 2023 highlighted several key developments: High-Consequence Infectious Diseases (HCIDs): The UK Health Security Agency (UKHSA) released a summary of global HCID events, including updates on diseases like Crimean-Congo Hemorrhagic Fever (CCHF) and Avian Influenza A (H5N1) These reports provide risk assessments and insights into outbreaks and their…
In November 2023, updates on health services for Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), highlighted several key developments: Integrated Care Boards (ICBs): ICBs are responsible for commissioning specialist ME/CFS services tailored to the needs of their local populations, subject to prioritization and funding Interim Delivery Plan: The government continued consultations on…
Research and discussions in November 2023 explored the relationship between Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), and coronavirus. Key highlights include: Shared Symptoms: Both ME/CFS and Long Covid exhibit overlapping symptoms, such as persistent fatigue, cognitive difficulties, and post-exertional malaise Biological Mechanisms: Studies have investigated immune system dysregulation and oxidative stress…
Research into Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), in November 2023 highlighted several key developments: Antibody Response Studies: A study explored the antibody response to Epstein-Barr Virus (EBV) to determine its potential as a diagnostic biomarker for ME/CFS Findings revealed that while individual antibodies couldn’t distinguish ME/CFS patients from healthy controls,…
The UK government has outlined a delivery plan to enhance support for children and young people living with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Key highlights include: Interim Delivery Plan: Published on 9 August 2023, the plan identifies 21 actions aimed at improving understanding, research, and care for ME/CFS. Specific focus areas include education, social care,…
In September 2023, updates on health services for Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), highlighted several key developments: Interim Delivery Plan: The UK government published an interim delivery plan titled “My Full Reality” on 9 August 2023. This plan outlines 21 actions to enhance understanding, research, and care for ME/CFS. The…
Postural Tachycardia Syndrome (PoTS) is a condition affecting the autonomic nervous system, leading to symptoms like rapid heart rate, dizziness, and fatigue upon standing. Key updates from July 2023 include: Pharmacological Treatments: Medications such as beta-blockers, fludrocortisone, and midodrine are commonly used to manage PoTS symptoms. Research continues to explore new drug therapies to improve…
The UK government has outlined a comprehensive plan to support individuals living with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Key highlights include: Interim Delivery Plan: Published in August 2023, the plan identifies 21 actions aimed at improving understanding, research, and care for ME/CFS. It focuses on three main themes: research, attitudes and education, and living with…